Vivani Medical (Vivani Medical) Risk Assessment

View and export this data going back to 2022. Start your Free Trial

What is Vivani Medical Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Vivani Medical is: No Data: Cannot be evaluated.

Competitive Comparison of Vivani Medical's Risk Assessment

For the Biotechnology subindustry, Vivani Medical's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vivani Medical's Risk Assessment Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivani Medical's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Vivani Medical's Risk Assessment falls into.

Vivani Medical (NAS:VANI) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Vivani Medical Risk Assessment Related Terms

Thank you for viewing the detailed overview of Vivani Medical's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivani Medical (Vivani Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivani Medical Inc (NAS:VANI) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

U5P:Germany

Address

5858 Horton Street, Suite 280, Emeryville, CA, USA, 94608

Website

https://www.vivani.com

Vivani Medical Inc is a preclinical stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases.

Executives

Gregg Williams	director, 10 percent owner	PO BOX 200, WALLED LAKE MI 48390-0200
Brigid Makes	officer: CFO	20245 SW 95TH AVENUE, TUALATIN OR 97062
Donald Dwyer	officer: Chief Business Officer	54 CHERRY FARM LANE, WEST CHESTER PA 19382
Aaron Mendelsohn	director	224 15TH STREET, SANTA MONICA CA 90402
Joachim Eberhard Bolck	10 percent owner	33 CLUB VIEW LANE, ROLLING HILLS ESTATES CA 90274
Lisa Ellen Porter	officer: Chief Medical Officer	778 CORDILLERAS AVE, SAN CARLOS CA 94070
Truc Le	officer: COO	1905 WEST RED FOX ROAD, SANTA ANA CA 92704
Adam Mendelsohn	director, officer: CEO	C/O 5858 HORTON ST. SUITE 280, EMERYVILLE CA 94608
Wilford Dean Baker	director	200 FLYNN ROAD, CAMARILLO CA 93012-8790
Larson Alexandra L.p.	director	3797 BURNING TREE DRIVE, BLOOMFIELD HILLS MI 48302
Scott Dunbar	officer: Acting CEO	13170 TELFAIR AVENUE, SYLMAR CA 91342
Edward Jonathon Sedo	officer: Controller	4485 FORESTGLEN CT, MOORPARK CA 93021
Jessy Dana Dorn	officer: VP-Clin & Scientific Affairs	12744 SAN FERNANDO RD. SUITE 400, SYLMAR CA 91342
Matthew J Pfeffer	director
Patrick Ryan	officer: Chief Operating Officer	C/O SECOND SIGHT MEDICAL PRODUCTS, INC., 12744 SAN FERNANDO ROAD, SUITE 400, SYLMAR CA 91342